--- type: entity entity_type: research_program name: Medicare GLP-1 Bridge Program domain: health status: active start_date: 2026-07-01 end_date: 2026-12-31 parent_organization: Centers for Medicare & Medicaid Services (CMS) --- # Medicare GLP-1 Bridge Program A temporary demonstration program providing Medicare Part D coverage for GLP-1 receptor agonists (Wegovy and Zepbound) for obesity treatment from July 1 to December 31, 2026. ## Program Structure **Eligibility:** - BMI ≥35 alone, or ≥27 with clinical criteria - Must be enrolled in Medicare Part D - Estimated ~14 million Medicare beneficiaries had diagnosed overweight/obesity in 2020 (potential eligible pool) **Cost-sharing:** - Fixed $50 copayment per prescription - Copay does NOT count toward Part D deductible or $2,100 out-of-pocket cap - Low-Income Subsidy (LIS) cost-sharing subsidies do NOT apply to prescriptions filled under this program **Legal Architecture:** - Operates outside standard Part D benefit structures because Medicare is statutorily prohibited from covering weight-loss drugs - Requires CMS demonstration authority, not legislative change - Temporary exception, not durable coverage ## Structural Issues The program's placement outside Part D cost-sharing structures makes Low-Income Subsidy (LIS) protections inapplicable, creating a $50 copay barrier for the lowest-income beneficiaries despite inclusive eligibility criteria. This represents a structural misalignment where coverage expansion and coverage restriction occur simultaneously through different layers of program design. ## Relationship to Other Programs - **BALANCE Model (Medicare Part D):** Longer demonstration launching January 2027 - **BALANCE Model (Medicaid):** Begins May 2026 - Beneficiaries seeking continued coverage in 2027 may need to switch Part D plans during open enrollment ## Timeline - **2026-04** — Program details announced by CMS - **2026-07-01** — Program begins - **2026-12-31** — Program ends ## Sources - KFF Health Policy analysis (April 2026) - CMS program documents